Prime Medicine Inc
PRME
NASDAQ
Biotechnology
$3.09
USD
-0.08 (-2.52%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $574.96M
Volume 1.6M
Price Target
$8.00 – $8.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $8.00 and a min estimate of $8.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$8.00
-$3.0 vs prior
Implied Upside
+158.9%
-97.1% vs prior
Analyst Covering
1
Unchanged vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Arthur He | HC Wainwright & Co. | Buy | Reiterated | 5 days ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
CCCC
C4 Therapeutics, Inc
$4.24
▲ +3.9%
EIKN
Eikon Therapeutics Inc
$11.05
▲ +7.0%
ARTV
Artiva Biotherapeutics Inc
$11.45
▲ +1.3%
MDXG
MiMedx Group Inc
$4.27
▲ +1.7%
ZURA
Zura Bio Ltd
$5.57
▼ -1.1%
VSTM
Verastem Inc
$6.58
▼ -1.4%
ALT
Altimmune Inc
$2.94
▲ +2.1%
NVCT
Nuvectis Pharma Inc
$18.96
▼ -1.4%
SPRY
ARS Pharmaceuticals Inc
$5.65
▼ -7.4%